Iranian Red Crescent Medical Journal

Published by: Kowsar

Correlation Between Serum Cartilage Oligomeric Matrix Protein (COMP), 25-Hydroxy Vitamin D, and Disease Activity in Patients with Knee Osteoarthritis

Mohammad Reza Jafari Nakhjavani 1 , Amir Ghorbanihaghjo 2 , Ozra Dabagh Asadollahipour 1 , Sima Abedi Azar 3 , Tala Pourlak 1 and Aida Malek Mahdavi 1 , *
Authors Information
1 Connective Tissue Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
2 Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
3 Kidney Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
Article information
  • Iranian Red Crescent Medical Journal: 21 (5); e91113
  • Published Online: May 21, 2019
  • Article Type: Research Article
  • Received: March 1, 2019
  • Revised: April 25, 2019
  • Accepted: April 30, 2019
  • DOI: 10.5812/ircmj.91113

To Cite: Jafari Nakhjavani M R , Ghorbanihaghjo A, Dabagh Asadollahipour O , Abedi Azar S , Pourlak T , et al. Correlation Between Serum Cartilage Oligomeric Matrix Protein (COMP), 25-Hydroxy Vitamin D, and Disease Activity in Patients with Knee Osteoarthritis, Iran Red Crescent Med J. Online ahead of Print ; 21(5):e91113. doi: 10.5812/ircmj.91113.

Copyright © 2019, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Johnson VL, Hunter DJ. The epidemiology of osteoarthritis. Best Pract Res Clin Rheumatol. 2014;28(1):5-15. doi: 10.1016/j.berh.2014.01.004. [PubMed: 24792942].
  • 2. Najm WI, Reinsch S, Hoehler F, Tobis JS, Harvey PW. S-adenosyl methionine (SAMe) versus celecoxib for the treatment of osteoarthritis symptoms: a double-blind cross-over trial. [ISRCTN36233495]. BMC Musculoskelet Disord. 2004;5(6):1-15. doi: 10.1186/1471-2474-5-6. [PubMed: 15102339]. [PubMed Central: PMC387830].
  • 3. Bellare N, Argekar H, Bhagwat A, Situt V, Pandita N. Glucosamine and chondroitin sulphate supplementation along with diet therapy provides better symptomatic relief in osteoarthritic patients as compared to diet therapy alone. Int J Pharm Sci Rev Res. 2014;24(1):215-23.
  • 4. Sowers M. Epidemiology of risk factors for osteoarthritis: systemic factors. Curr Opin Rheumatol. 2001;13(5):447-51. [PubMed: 11604603].
  • 5. Verma P, Dalal K. Serum cartilage oligomeric matrix protein (COMP) in knee osteoarthritis: A novel diagnostic and prognostic biomarker. J Orthop Res. 2013;31(7):999-1006. doi: 10.1002/jor.22324. [PubMed: 23423905].
  • 6. El-Arman MM, El-Fayoumi G, El-Shal E, El-Boghdady I, El-Ghaweet A. Aggrecan and cartilage oligomeric matrix protein in serum and synovial fluid of patients with knee osteoarthritis. HSS J. 2010;6(2):171-6. doi: 10.1007/s11420-010-9157-0. [PubMed: 21886532]. [PubMed Central: PMC2926364].
  • 7. Smith RK, Heinegard D. Cartilage oligomeric matrix protein (COMP) levels in digital sheath synovial fluid and serum with tendon injury. Equine Vet J. 2000;32(1):52-8. [PubMed: 10661386].
  • 8. Robinson WH, Lindstrom TM, Cheung RK, Sokolove J. Mechanistic biomarkers for clinical decision making in rheumatic diseases. Nat Rev Rheumatol. 2013;9(5):267-76. doi: 10.1038/nrrheum.2013.14. [PubMed: 23419428]. [PubMed Central: PMC3673766].
  • 9. Saberi Hosnijeh F, Siebuhr AS, Uitterlinden AG, Oei EH, Hofman A, Karsdal MA, et al. Association between biomarkers of tissue inflammation and progression of osteoarthritis: evidence from the Rotterdam study cohort. Arthritis Res Ther. 2016;18:81. doi: 10.1186/s13075-016-0976-3. [PubMed: 27039382]. [PubMed Central: PMC4818486].
  • 10. Hussein DA, El Bakry SA, Morshedy NA, Ibrahim SE, Sakr HM, Abo-Shady RA. Role of cartilage oligomeric matrix protein (COMP) as a prognostic biomarker in follow-up of early rheumatoid arthritis patients: Correlation to musculoskeletal ultrasonographic findings. The Egyptian Rheumatologist. 2018;40(4):221-6. doi: 10.1016/j.ejr.2018.01.006.
  • 11. Bergink AP, Zillikens MC, Van Leeuwen JP, Hofman A, Uitterlinden AG, van Meurs JB. 25-Hydroxyvitamin D and osteoarthritis: A meta-analysis including new data. Semin Arthritis Rheum. 2016;45(5):539-46. doi: 10.1016/j.semarthrit.2015.09.010. [PubMed: 26522138].
  • 12. Tetlow LC, Woolley DE. Expression of vitamin D receptors and matrix metalloproteinases in osteoarthritic cartilage and human articular chondrocytes in vitro. Osteoarthritis Cartilage. 2001;9(5):423-31. doi: 10.1053/joca.2000.0408. [PubMed: 11467890].
  • 13. Dretakis OE, Tsatsanis C, Fyrgadis A, Drakopoulos CG, Steriopoulos K, Margioris AN. Correlation between serum 25-hydroxyvitamin D levels and quadriceps muscle strength in elderly cretans. J Int Med Res. 2010;38(5):1824-34. doi: 10.1177/147323001003800530. [PubMed: 21309499].
  • 14. Segal NA, Glass NA. Is quadriceps muscle weakness a risk factor for incident or progressive knee osteoarthritis? Phys Sportsmed. 2011;39(4):44-50. doi: 10.3810/psm.2011.11.1938. [PubMed: 22293767].
  • 15. Bennell KL, Wrigley TV, Hunt MA, Lim BW, Hinman RS. Update on the role of muscle in the genesis and management of knee osteoarthritis. Rheum Dis Clin North Am. 2013;39(1):145-76. doi: 10.1016/j.rdc.2012.11.003. [PubMed: 23312414].
  • 16. Breijawi N, Eckardt A, Pitton MB, Hoelzl AJ, Giesa M, von Stechow D, et al. Bone mineral density and vitamin D status in female and male patients with osteoarthritis of the knee or hip. Eur Surg Res. 2009;42(1):1-10. doi: 10.1159/000166164. [PubMed: 18971579].
  • 17. Chaganti RK, Parimi N, Cawthon P, Dam TL, Nevitt MC, Lane NE. Association of 25-hydroxyvitamin D with prevalent osteoarthritis of the hip in elderly men: the osteoporotic fractures in men study. Arthritis Rheum. 2010;62(2):511-4. doi: 10.1002/art.27241. [PubMed: 20112402]. [PubMed Central: PMC3787848].
  • 18. Heidari B, Heidari P, Hajian-Tilaki K. Association between serum vitamin D deficiency and knee osteoarthritis. Int Orthop. 2011;35(11):1627-31. doi: 10.1007/s00264-010-1186-2. [PubMed: 21191580]. [PubMed Central: PMC3193973].
  • 19. Hunter DJ, Hart D, Snieder H, Bettica P, Swaminathan R, Spector TD. Evidence of altered bone turnover, vitamin D and calcium regulation with knee osteoarthritis in female twins. Rheumatology (Oxford). 2003;42(11):1311-6. doi: 10.1093/rheumatology/keg373. [PubMed: 12867590].
  • 20. Kalichman L, Kobyliansky E. Association between circulatory levels of vitamin D and radiographic hand osteoarthritis. Rheumatol Int. 2012;32(1):253-7. doi: 10.1007/s00296-010-1741-6. [PubMed: 21240496].
  • 21. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum. 1986;29(8):1039-49. [PubMed: 3741515].
  • 22. Wislowska M, Jablonska B. Serum cartilage oligomeric matrix protein (COMP) in rheumatoid arthritis and knee osteoarthritis. Clin Rheumatol. 2005;24(3):278-84. doi: 10.1007/s10067-004-1000-x. [PubMed: 15940561].
  • 23. Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis. 1957;16(4):494-502. doi: 10.1136/ard.16.4.494. [PubMed: 13498604]. [PubMed Central: PMC1006995].
  • 24. Colucci S, Mori G, Vaira S, Brunetti G, Greco G, Mancini L, et al. L-carnitine and isovaleryl L-carnitine fumarate positively affect human osteoblast proliferation and differentiation in vitro. Calcif Tissue Int. 2005;76(6):458-65. doi: 10.1007/s00223-004-0147-4. [PubMed: 15906015].
  • 25. Eftekharsadat B, Toopchizadeh V, Sadeghi H, Niknejad SH. Validity and reliability of the Persian versions of WOMAC questionnaire in Knee Osteoarthritis. PM&R specialty graduation thesis, Tabriz University of Medical Sciences; 2012.
  • 26. Darwish AF, Abdel-Ghany HS, El-Sherbini YM. Diagnostic and prognostic value of some biochemical markers in early knee osteoarthritis. Egypt Rheumatol. 2012;34(1):1-8. doi: 10.1016/j.ejr.2011.09.001.
  • 27. Hoch JM, Mattacola CG, Medina McKeon JM, Howard JS, Lattermann C. Serum cartilage oligomeric matrix protein (sCOMP) is elevated in patients with knee osteoarthritis: A systematic review and meta-analysis. Osteoarthritis Cartilage. 2011;19(12):1396-404. doi: 10.1016/j.joca.2011.09.005. [PubMed: 22001901]. [PubMed Central: PMC3962955].
  • 28. Posey KL, Coustry F, Hecht JT. Cartilage oligomeric matrix protein: COMPopathies and beyond. Matrix Biol. 2018;71-72:161-73. doi: 10.1016/j.matbio.2018.02.023. [PubMed: 29530484]. [PubMed Central: PMC6129439].
  • 29. Vilim V, Olejarova M, Machacek S, Gatterova J, Kraus VB, Pavelka K. Serum levels of cartilage oligomeric matrix protein (COMP) correlate with radiographic progression of knee osteoarthritis. Osteoarthritis Cartilage. 2002;10(9):707-13. [PubMed: 12202123].
  • 30. Clark AG, Jordan JM, Vilim V, Renner JB, Dragomir AD, Luta G, et al. Serum cartilage oligomeric matrix protein reflects osteoarthritis presence and severity: The Johnston County Osteoarthritis Project. Arthritis Rheum. 1999;42(11):2356-64. doi: 10.1002/1529-0131(199911)42:11<2356::AID-ANR14>3.0.CO;2-R. [PubMed: 10555031].
  • 31. Zhang J. Meta-analysis of serum C-reactive protein and cartilage oligomeric matrix protein levels as biomarkers for clinical knee osteoarthritis. BMC Musculoskelet Disord. 2018;19(1):22. doi: 10.1186/s12891-018-1932-y. [PubMed: 29351749]. [PubMed Central: PMC5775565].
  • 32. Bruyere O, Collette JH, Ethgen O, Rovati LC, Giacovelli G, Henrotin YE, et al. Biochemical markers of bone and cartilage remodeling in prediction of longterm progression of knee osteoarthritis. J Rheumatol. 2003;30(5):1043-50. [PubMed: 12734904].
  • 33. Cranney A, Weiler HA, O'Donnell S, Puil L. Summary of evidence-based review on vitamin D efficacy and safety in relation to bone health. Am J Clin Nutr. 2008;88(2):513S-9S. doi: 10.1093/ajcn/88.2.513S. [PubMed: 18689393].
  • 34. McAlindon T, LaValley M, Schneider E, Nuite M, Lee JY, Price LL, et al. Effect of vitamin D supplementation on progression of knee pain and cartilage volume loss in patients with symptomatic osteoarthritis: A randomized controlled trial. JAMA. 2013;309(2):155-62. doi: 10.1001/jama.2012.164487. [PubMed: 23299607]. [PubMed Central: PMC3984919].
  • 35. Cakar M, Ayanoglu S, Cabuk H, Seyran M, Dedeoglu SS, Gurbuz H. Association between vitamin D concentrations and knee pain in patients with osteoarthritis. PeerJ. 2018;6. e4670. doi: 10.7717/peerj.4670. [PubMed: 29707434]. [PubMed Central: PMC5922228].
  • 36. Konstari S, Paananen M, Heliovaara M, Knekt P, Marniemi J, Impivaara O, et al. Association of 25-hydroxyvitamin D with the incidence of knee and hip osteoarthritis: A 22-year follow-up study. Scand J Rheumatol. 2012;41(2):124-31. doi: 10.3109/03009742.2011.617314. [PubMed: 22043944].
  • 37. Felson DT, Niu J, Clancy M, Aliabadi P, Sack B, Guermazi A, et al. Low levels of vitamin D and worsening of knee osteoarthritis: Results of two longitudinal studies. Arthritis Rheum. 2007;56(1):129-36. doi: 10.1002/art.22292. [PubMed: 17195215].
  • 38. Ding C, Cicuttini F, Parameswaran V, Burgess J, Quinn S, Jones G. Serum levels of vitamin D, sunlight exposure, and knee cartilage loss in older adults: The Tasmanian older adult cohort study. Arthritis Rheum. 2009;60(5):1381-9. doi: 10.1002/art.24486. [PubMed: 19404958].
  • 39. Muraki S, Dennison E, Jameson K, Boucher BJ, Akune T, Yoshimura N, et al. Association of vitamin D status with knee pain and radiographic knee osteoarthritis. Osteoarthritis Cartilage. 2011;19(11):1301-6. doi: 10.1016/j.joca.2011.07.017. [PubMed: 21884812].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments